BQE-23716-74915
3 vaccinations
1 coded response
12 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 778 / TX
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Registered in v-safe
-
2021-01-06
Dose 1 — Pfizer-BioNTech
- 2021-01-06
- 2021-01-15
- 2021-01-21
-
2021-01-28
Dose 2 — Pfizer-BioNTech
- 2021-01-29
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-11
-
2021-02-18
Survey response — day 21, dose 2MedDRA: Fatigue, Nasal congestion, Pyrexia, Rhinorrhoea — Feeling: FairFree text: Fatigue, nasal congestion, runny nose, feverish feelingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-04
-
2021-12-21
Dose 3 — Pfizer-BioNTech
- 2022-01-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | |
| 2 | 2021-01-28 | Pfizer-BioNTech | |
| 3 | 2021-12-21 | Pfizer-BioNTech | No |
Free text
Release 4 — day 21, dose 2
Symptoms: Fatigue, nasal congestion, runny nose, feverish feeling
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release